Management of Leimyosarcoma: A Survey Among Members of the Korean Gynecologic Oncology Group

    loading  Checking for direct PDF access through Ovid



This study aimed to investigate current clinical management of leiomyosarcoma (LMS) in Korea.

Materials and Methods

We conducted a Web-based survey among members of the Korean Gynecologic Oncology Group regarding their treatment of LMS.


In total, 77 (27.8%) of 277 members responded to the survey. For surgical treatment of stage I LMS, 26.8% indicated total hysterectomy only and 16.9% indicated total hysterectomy with bilateral salpingo-oophorectomy. Also, lymph node dissection was indicated by 54.9% of respondents, whereas 46.5% stated that bilateral salpingo-oophorectomy could be omitted in young patients. More than half (57.7%) of the respondents recommended against adjuvant treatment. For stage I LMS diagnosed after morcellation, 79.2% of the respondents recommended lymph node dissection and 56.4% recommended adjuvant therapy. As for advanced-stage LMS, in cases of complete resection, adjuvant chemotherapy was preferred by 63.1%. For incomplete resection, combined radiotherapy/chemotherapy was the most preferred adjuvant therapy (63.1%).


Among Korean Gynecologic Oncology Group members, there are many discrepancies in the clinical management of LMS. A large-scale prospective study to establish treatment guidelines is needed.

Related Topics

    loading  Loading Related Articles